Chi­na's CRO pow­er­house Tigermed to seek $1B IPO in Hong Kong — re­port

Hong Kong’s ef­fer­ves­cent bio­phar­ma IPO mar­ket could see its biggest de­but of the year yet.

Hangzhou Tigermed, a clin­i­cal re­search ser­vice provider that al­so in­vests …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER